Logo image of CXM

SPRINKLR INC-A (CXM) Stock Fundamental Analysis

NYSE:CXM - New York Stock Exchange, Inc. - US85208T1079 - Common Stock - Currency: USD

8.62  -0.06 (-0.69%)

Premarket: 8.6697 +0.05 (+0.58%)

Fundamental Rating

5

CXM gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 282 industry peers in the Software industry. CXM has an average financial health and profitability rating. CXM is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year CXM was profitable.
CXM had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: CXM reported negative net income in multiple years.
CXM had a positive operating cash flow in 4 of the past 5 years.
CXM Yearly Net Income VS EBIT VS OCF VS FCFCXM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 2025 0 50M -50M 100M -100M

1.2 Ratios

Looking at the Return On Assets, with a value of 9.20%, CXM belongs to the top of the industry, outperforming 85.82% of the companies in the same industry.
Looking at the Return On Equity, with a value of 17.10%, CXM belongs to the top of the industry, outperforming 84.40% of the companies in the same industry.
CXM has a Return On Invested Capital of 4.36%. This is in the better half of the industry: CXM outperforms 74.11% of its industry peers.
Industry RankSector Rank
ROA 9.2%
ROE 17.1%
ROIC 4.36%
ROA(3y)3.01%
ROA(5y)-1.91%
ROE(3y)5.76%
ROE(5y)-4.85%
ROIC(3y)N/A
ROIC(5y)N/A
CXM Yearly ROA, ROE, ROICCXM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 2025 0 100 -100 -200

1.3 Margins

Looking at the Profit Margin, with a value of 13.58%, CXM belongs to the top of the industry, outperforming 80.85% of the companies in the same industry.
CXM has a Operating Margin of 4.42%. This is in the better half of the industry: CXM outperforms 71.28% of its industry peers.
The Gross Margin of CXM (71.05%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of CXM has grown nicely.
Industry RankSector Rank
OM 4.42%
PM (TTM) 13.58%
GM 71.05%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1%
GM growth 5Y3.08%
CXM Yearly Profit, Operating, Gross MarginsCXM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CXM is destroying value.
The number of shares outstanding for CXM has been reduced compared to 1 year ago.
CXM has more shares outstanding than it did 5 years ago.
There is no outstanding debt for CXM. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CXM Yearly Shares OutstandingCXM Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
CXM Yearly Total Debt VS Total AssetsCXM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.2 Solvency

An Altman-Z score of 2.84 indicates that CXM is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.84, CXM is in line with its industry, outperforming 56.03% of the companies in the same industry.
There is no outstanding debt for CXM. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 2.84
ROIC/WACC0.41
WACC10.76%
CXM Yearly LT Debt VS Equity VS FCFCXM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

2.3 Liquidity

A Current Ratio of 1.74 indicates that CXM should not have too much problems paying its short term obligations.
CXM has a Current ratio of 1.74. This is comparable to the rest of the industry: CXM outperforms 54.61% of its industry peers.
A Quick Ratio of 1.74 indicates that CXM should not have too much problems paying its short term obligations.
CXM's Quick ratio of 1.74 is in line compared to the rest of the industry. CXM outperforms 55.32% of its industry peers.
Industry RankSector Rank
Current Ratio 1.74
Quick Ratio 1.74
CXM Yearly Current Assets VS Current LiabilitesCXM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

4

3. Growth

3.1 Past

The earnings per share for CXM have decreased by -9.52% in the last year.
The Revenue has been growing slightly by 6.75% in the past year.
Measured over the past years, CXM shows a quite strong growth in Revenue. The Revenue has been growing by 19.68% on average per year.
EPS 1Y (TTM)-9.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
Revenue 1Y (TTM)6.75%
Revenue growth 3Y17.38%
Revenue growth 5Y19.68%
Sales Q2Q%4.87%

3.2 Future

Based on estimates for the next years, CXM will show a small growth in Earnings Per Share. The EPS will grow by 5.36% on average per year.
Based on estimates for the next years, CXM will show a quite strong growth in Revenue. The Revenue will grow by 8.62% on average per year.
EPS Next Y15.21%
EPS Next 2Y11.81%
EPS Next 3Y11.41%
EPS Next 5Y5.36%
Revenue Next Year3.97%
Revenue Next 2Y4.42%
Revenue Next 3Y5.52%
Revenue Next 5Y8.62%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CXM Yearly Revenue VS EstimatesCXM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M 1B
CXM Yearly EPS VS EstimatesCXM Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.2 -0.2 0.4

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 22.68 indicates a rather expensive valuation of CXM.
Based on the Price/Earnings ratio, CXM is valued a bit cheaper than the industry average as 76.95% of the companies are valued more expensively.
CXM is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.18, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 19.70, the valuation of CXM can be described as rather expensive.
CXM's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. CXM is cheaper than 77.66% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 35.34. CXM is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 22.68
Fwd PE 19.7
CXM Price Earnings VS Forward Price EarningsCXM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

80.50% of the companies in the same industry are more expensive than CXM, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CXM indicates a somewhat cheap valuation: CXM is cheaper than 79.79% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 21.58
EV/EBITDA 22.28
CXM Per share dataCXM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of CXM may justify a higher PE ratio.
PEG (NY)1.49
PEG (5Y)N/A
EPS Next 2Y11.81%
EPS Next 3Y11.41%

0

5. Dividend

5.1 Amount

No dividends for CXM!.
Industry RankSector Rank
Dividend Yield N/A

SPRINKLR INC-A

NYSE:CXM (7/15/2025, 8:04:00 PM)

Premarket: 8.6697 +0.05 (+0.58%)

8.62

-0.06 (-0.69%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)06-04 2025-06-04/bmo
Earnings (Next)09-02 2025-09-02/amc
Inst Owners79.44%
Inst Owner Change0.02%
Ins Owners6.03%
Ins Owner Change44.72%
Market Cap2.23B
Analysts65.88
Price Target9.89 (14.73%)
Short Float %10.21%
Short Ratio5.3
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)30.14%
Min EPS beat(2)21.24%
Max EPS beat(2)39.04%
EPS beat(4)3
Avg EPS beat(4)17.48%
Min EPS beat(4)-14.78%
Max EPS beat(4)39.04%
EPS beat(8)7
Avg EPS beat(8)34.7%
EPS beat(12)11
Avg EPS beat(12)104.49%
EPS beat(16)15
Avg EPS beat(16)86.72%
Revenue beat(2)1
Avg Revenue beat(2)0.39%
Min Revenue beat(2)-0.02%
Max Revenue beat(2)0.8%
Revenue beat(4)3
Avg Revenue beat(4)0.58%
Min Revenue beat(4)-0.02%
Max Revenue beat(4)1.16%
Revenue beat(8)6
Avg Revenue beat(8)1.02%
Revenue beat(12)9
Avg Revenue beat(12)0.95%
Revenue beat(16)13
Avg Revenue beat(16)1.74%
PT rev (1m)-5.75%
PT rev (3m)-8.71%
EPS NQ rev (1m)0.03%
EPS NQ rev (3m)4.34%
EPS NY rev (1m)4.45%
EPS NY rev (3m)4.24%
Revenue NQ rev (1m)0.12%
Revenue NQ rev (3m)1.03%
Revenue NY rev (1m)0.49%
Revenue NY rev (3m)0.37%
Valuation
Industry RankSector Rank
PE 22.68
Fwd PE 19.7
P/S 2.77
P/FCF 21.58
P/OCF 18.65
P/B 3.49
P/tB 3.78
EV/EBITDA 22.28
EPS(TTM)0.38
EY4.41%
EPS(NY)0.44
Fwd EY5.08%
FCF(TTM)0.4
FCFY4.63%
OCF(TTM)0.46
OCFY5.36%
SpS3.11
BVpS2.47
TBVpS2.28
PEG (NY)1.49
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 9.2%
ROE 17.1%
ROCE 5.13%
ROIC 4.36%
ROICexc 24.79%
ROICexgc 42.07%
OM 4.42%
PM (TTM) 13.58%
GM 71.05%
FCFM 12.83%
ROA(3y)3.01%
ROA(5y)-1.91%
ROE(3y)5.76%
ROE(5y)-4.85%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1%
GM growth 5Y3.08%
F-Score7
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 86.2%
Cap/Sales 2.02%
Interest Coverage 250
Cash Conversion 219.67%
Profit Quality 94.52%
Current Ratio 1.74
Quick Ratio 1.74
Altman-Z 2.84
F-Score7
WACC10.76%
ROIC/WACC0.41
Cap/Depr(3y)122.21%
Cap/Depr(5y)126.89%
Cap/Sales(3y)2.58%
Cap/Sales(5y)2.39%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-9.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
EPS Next Y15.21%
EPS Next 2Y11.81%
EPS Next 3Y11.41%
EPS Next 5Y5.36%
Revenue 1Y (TTM)6.75%
Revenue growth 3Y17.38%
Revenue growth 5Y19.68%
Sales Q2Q%4.87%
Revenue Next Year3.97%
Revenue Next 2Y4.42%
Revenue Next 3Y5.52%
Revenue Next 5Y8.62%
EBIT growth 1Y-16.89%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year97.65%
EBIT Next 3Y38.13%
EBIT Next 5Y27.49%
FCF growth 1Y241.27%
FCF growth 3YN/A
FCF growth 5Y33.79%
OCF growth 1Y148.61%
OCF growth 3YN/A
OCF growth 5Y32.54%